Last reviewed · How we verify

NCT03742531

Does Induction Dosage in Latent Phase Affect Active Phase of Labor?

Completed Phase 2 Last updated 20 January 2021
What this trial tests

Phase 2 trial testing oxytocin in Oxytocin in 300 participants. Completed in 1 December 2019.

Timeline
15 December 2018
Primary endpoint
15 June 2019
1 December 2019

Quick facts

Lead sponsorZeynep Kamil Maternity and Pediatric Research and Training Hospital
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment300
Start date15 December 2018
Primary completion15 June 2019
Estimated completion1 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Who can join

Adults 18 to 40, female only, with Oxytocin or Induction of Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the need of oxytocin therapy in active phase of labor. there will be two groups treating with oxytocin in latent phase.One group will be treated with low dose oxytocin therapy and the other group will be treated with high dose oxytocin therapy. oxytocin treatment will be ceased at the beginning of the active phase of labor. the need of oxytocin treatment in active phase of labor will be compared between two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of oxytocin

Trials testing the same drug.

Other recruiting trials for Oxytocin

Currently open trials in the same condition.

Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03742531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing